Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Filings indexed 1,068 across all filing types
Latest filing 2026-05-13 Share Issue/Capital Cha…
Country SE Sweden
Listing ST VIVE

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Vivesto offentliggör tidplan för sammanläggning av aktier
Share Issue/Capital Change Classification · 91% confidence The document is a press release announcing a 1:100 share consolidation (capital change) with details on the record date, trading dates, and new ISIN – it is an announcement of a capital change (share consolidation). This clearly falls under Share Issue/Capital Change.
2026-05-13 Swedish
Vivesto announces timetable for reverse share split
Share Issue/Capital Change Classification · 11% confidence The document is a press release announcing the timetable for a reverse share split (1:100), detailing record dates, ISIN change, and effects on share capital. This is a capital structure change. According to the definitions, announcements of stock splits or capital changes fall under “Share Issue/Capital Change” (SHA). It is not a financing update or regulatory filing announcement; it is a direct capital change announcement itself.
2026-05-13 English
Kommuniké från årsstämma i Vivesto AB
Regulatory Filings
2026-05-07 English
Report from Annual General Meeting in Vivesto AB
Regulatory Filings
2026-05-07 English
Quarterly Report 2026
Quarterly Report
2026-05-07 English
Annual Report 2025
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2025' (Annual Report 2025) for the company Vivesto. It contains a comprehensive overview of the company's activities, financial statements, notes, board of directors' report, and auditor's report. It is clearly the full annual report for the fiscal year 2025, not an announcement or a summary. FY 2025
2026-04-13 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.